Episode 497: Taking Back Control of Chronic Pain

Chronic pain originated from genetic degenerative disc disease after the birth of her second child, leading to muscle spasms, failed artificial disc implant (FDA trial), spinal fusion, and permanent nerve damage in both legs. At peak pharmaceutical use, Shelley was on approximately seven medications — including pain, antidepressant, anxiety, insomnia, nausea, and panic medications — with five taken daily. Side effects from pharmaceuticals included nausea, vomiting, appetite loss, hair loss, poor nail and dental health, and chronic lack of deep sleep. Cannabis was first introduced by her Colorado chronic pain specialist, who permitted concurrent use with pain medication; she began with edibles primarily to address severe appetite loss and weight loss. Beyond appetite, cannabis progressively reduced anxiety, stress, and other symptoms, surprising Shelley given her Gen X perception of it as a "stoner drug." Her doctor's indictment for Medicare fraud in Colorado — abandoning 250+ patients overnight and destroying records — forced a pivotal choice; she opted to transition fully to cannabis rather than restart the pharmaceutical advocacy process. Going cold turkey off pain medication in 2020 was manageable partly because cannabis had already built mental resilience, contrasting with pharmaceuticals which she felt made her mentally unstable. Shelley noted it took approximately five years after stopping pharmaceuticals to feel chemically different — lighter and healed — underscoring the long-term impact of pharmaceutical residue. A spinal cord stimulator implanted roughly seven years into her chronic pain journey provided ~40% pain relief via leads and an internal battery; the leads are now burning out but she has decided against replacement surgery due to prior nerve damage risk. Current cannabis regimen: ~50mg hybrid edible (CBD/CBN blend) each morning plus smoking at night for relaxation and sleep, with the ability to self-regulate dosage by cutting down without withdrawal. Stigma encountered from her generation includes perceptions of cannabis as a lazy, unmotivated, or gateway drug — compounded by prior stigma as a chronic pain patient during the opioid epidemic. Cannabis is credited with delivering mental clarity and stability, directly countering the common misconception that it causes fogginess or impaired thinking. Chronic pain described as an all-consuming mental battle; cannabis enabled Shelley to stay present and mentally strong rather than constantly focused on pain — a key quality-of-life shift. Reflecting on her journey, Shelley's core message is to open the door to cannabis sooner, while acknowledging that everything happens in its own time. Visit our website: CannabisHealthRadio.comDiscover products and get expert advice from Swan ApothecaryFollow us on Facebook.Follow us on Instagram.Find us on Rumble.Keep your privacy! Buy NixT420 Odor Remover Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.